DaVita Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by DaVita Inc. on November 18, 2004. The filing discloses the entry into a material definitive employment agreement and the appointment of a new principal officer.
Key Financial Metrics
The filing does not report revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on executive compensation terms:
- Base Salary: $240,000 annually.
- Performance Bonus: Up to $120,000.
- Signing Bonus: $41,428.
- Stock Options: 60,000 shares with a five-year term.
- Restricted Stock Units: 6,250 shares.
Material Changes
The primary material change is the appointment of Joseph Schohl as Vice President, General Counsel, and Secretary, effective November 18, 2004. Mr. Schohl joins the company from Baxter International Inc., where he served as legal counsel from 1998 to 2004.
Outlook, Risks, and Unusual Items
Employment Terms and Termination: Mr. Schohl is an "at-will" employee. In the event of termination without cause, resignation for good cause, or constructive discharge, he is entitled to two years of base salary and one year of health benefits.
Change of Control: All stock options and restricted stock units will immediately vest upon a change of control. This is defined as a transaction where a person or group acquires greater than 40% of voting power, or specific merger/asset sale scenarios, unless Kent Thiry remains CEO or Executive Chair for at least one year post-transaction.
Restrictive Covenants: The agreement includes a two-year non-compete and non-solicitation clause covering employees, patients, physicians, and customers.
Investor Verification Checklist
- Verify the vesting schedule for the 60,000 stock options and 6,250 restricted stock units granted to Mr. Schohl.
- Confirm the specific definition of "Change of Control" regarding the retention of Kent Thiry.
- Review the potential financial impact of the two-year severance package if Mr. Schohl is terminated without cause.
- Assess any potential conflicts of interest given Mr. Schohl's prior employment at Baxter International Inc., a company with which DaVita conducts business.